NAGE
Niagen Bioscience, Inc.
NASDAQ: NAGE · HEALTHCARE · BIOTECHNOLOGY
$4.76
-1.65% today
Updated 2026-04-29
Market cap
$381.18M
P/E ratio
23.80
P/S ratio
2.95x
EPS (TTM)
$0.20
Dividend yield
—
52W range
$4 – $15
Volume
1.2M
Niagen Bioscience, Inc. (NAGE) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $4.51M | $5.78M | $7.57M | $8.11M | $11.61M | $10.16M | $15.31M | $17.88M | $21.66M | $21.20M | $31.56M | $46.29M | $59.26M | $67.45M | $72.05M | $83.57M | $99.60M | $129.42M |
| Revenue growth (YoY) | — | — | +28.2% | +31.0% | +7.2% | +43.1% | -12.5% | +50.7% | +16.8% | +21.1% | -2.1% | +48.8% | +46.7% | +28.0% | +13.8% | +6.8% | +16.0% | +19.2% | +29.9% |
| Cost of revenue | — | $3.27M | $3.74M | $4.62M | $5.64M | $9.34M | $7.03M | $9.99M | $10.35M | $11.27M | $10.72M | $15.50M | $20.52M | $23.98M | $25.96M | $29.25M | $32.79M | $38.01M | $46.23M |
| Gross profit | — | $1.23M | $2.04M | $2.94M | $2.47M | $2.28M | $3.13M | $5.33M | $7.53M | $10.39M | $10.48M | $16.05M | $25.77M | $35.27M | $41.49M | $42.80M | $50.78M | $61.59M | $83.19M |
| Gross margin | — | 27.3% | 35.3% | 38.9% | 30.5% | 19.6% | 30.8% | 34.8% | 42.1% | 48.0% | 49.4% | 50.9% | 55.7% | 59.5% | 61.5% | 59.4% | 60.8% | 61.8% | 64.3% |
| R&D | — | — | — | — | — | — | $134040.00 | $513671.00 | $891601.00 | $2.52M | $4.01M | $5.48M | $4.42M | $3.42M | $3.83M | $4.83M | $4.96M | $6.02M | $6.33M |
| SG&A | — | $2.57M | $2.10M | $3.88M | $7.80M | $8.39M | $4.98M | $7.86M | $7.20M | $9.21M | $17.64M | $27.14M | $34.31M | $30.77M | $36.38M | $28.29M | $24.98M | $18.38M | $62.56M |
| Operating income | $-38382.00 | $-2.06M | $-892732.00 | $-2.02M | $-7.86M | $-11.64M | $-4.39M | $-5.23M | $-2.07M | $-2.91M | $-16.38M | $-33.17M | $-31.30M | $-19.85M | $-27.07M | $-18.63M | $-5.60M | $7.73M | $14.30M |
| Operating margin | — | -45.8% | -15.5% | -26.7% | -96.9% | -100.2% | -43.2% | -34.2% | -11.6% | -13.4% | -77.2% | -105.1% | -67.6% | -33.5% | -40.1% | -25.9% | -6.7% | 7.8% | 11.0% |
| EBITDA | $-38382.00 | $-1.69M | $-498232.00 | $-1.63M | $-7.46M | $-11.29M | $-4.12M | $-4.97M | $-1.74M | $-2.49M | $-15.66M | $-32.33M | $-29.78M | $-18.34M | $-25.45M | $-16.74M | $-3.89M | $9.21M | $15.75M |
| EBITDA margin | — | -37.5% | -8.6% | -21.5% | -92.0% | -97.2% | -40.5% | -32.5% | -9.7% | -11.5% | -73.9% | -102.4% | -64.3% | -31.0% | -37.7% | -23.2% | -4.7% | 9.2% | 12.2% |
| EBIT | — | $-2.06M | $-892732.00 | $-2.02M | $-7.86M | $-11.63M | $-4.39M | $-5.23M | $-2.07M | $-2.91M | $-16.38M | $-33.17M | $-31.30M | $-19.85M | $-27.07M | $-18.63M | $-5.60M | $7.73M | $14.30M |
| Interest expense | — | $70079.00 | $17090.00 | $36068.00 | $32142.00 | $29006.00 | $34330.00 | $158849.00 | $616033.00 | $371899.00 | $153000.00 | $79000.00 | $847000.00 | $71000.00 | $55000.00 | — | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-38382.00 | $-2.10M | $-907568.00 | $-2.05M | $-7.89M | $-11.66M | $-4.42M | $-5.39M | $-2.77M | $-2.93M | $-11.38M | $-33.32M | $-32.15M | $-19.93M | $-27.13M | $-16.54M | $-4.94M | $8.55M | $17.38M |
| Net income growth (YoY) | — | -5383.0% | +56.9% | -126.1% | -284.8% | -47.7% | +62.1% | -21.9% | +48.6% | -5.7% | -288.6% | -192.8% | +3.5% | +38.0% | -36.2% | +39.0% | +70.1% | +273.1% | +103.3% |
| Profit margin | — | -46.7% | -15.7% | -27.1% | -97.3% | -100.4% | -43.5% | -35.2% | -15.5% | -13.5% | -53.7% | -105.6% | -69.4% | -33.6% | -40.2% | -23.0% | -5.9% | 8.6% | 13.4% |